DNTH

Dianthus Therapeutics Inc.

Price

$113.70

return (12m)

p/e

-33.41

p/bv

5.48

DIVIDEND YIELD

0.00%

DNTH price

Dianthus Therapeutics Inc.

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment DNTH

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

9.78%

3 months

26.85%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals DNTH

Valuation

P/E

-33.41

Sector 7.79

Industry 7.79

P/BV

5.48

Sector 2.11

Industry 2.11

P/Revenue (PSR)

3,380.93

Sector 2.22

Industry 2.22

EV/EBITDA

-90.21

Sector -156.98

Industry -156.98

EV/EBIT

-90.06

Sector -1,355,776,171.42

Industry -1,355,776,171.42

P/EBITDA

-29.54

Sector 2.51

Industry 2.51

P/EBIT

-29.49

Sector 0.34

Industry 0.34

P/Total Assets

5.29

Sector 1.00

Industry 1.00

P/Net Current Assets

7.50

Sector -3.84

Industry -3.84

P/Working Capital

7.44

Sector -5,077.26

Industry -5,077.26

EPS

-3.43

Sector 0.67

Industry 0.67

BVPS

20.93

Sector 10.17

Industry 10.17

Efficiency

Gross Margin

100.00%

Sector 32.61%

Industry 32.61%

EBITDA Margin

-8,076.32%

Sector -284.80%

Industry -284.80%

EBIT Margin

-8,089.47%

Sector -4.02%

Industry -4.02%

Operating Margin

-100.00%

Sector 4.45%

Industry 4.45%

Net Profit Margins

-100.00%

Sector 2.39%

Industry 2.39%

Asset Turnover

0.00

Sector 0.11

Industry 0.11

Profitability

ROE

-16.40%

Sector 2.05%

Industry 2.05%

ROA

-15.85%

Sector -0.90%

Industry -0.90%

ROIC

-108.15%

Sector -118.95%

Industry -118.95%

Dividends

Dividend yield

0.00%

Sector 0.60%

Industry 0.60%

Payout

Sector 11.53%

Industry 11.53%

Debt

Current Ratio

26.10

Sector 1.44

Industry 1.44

Net Debt / EBITDA

14.45

Sector -39,522,158.34

Industry -39,522,158.34

Net Debt / EBIT

14.42

Sector -31.03

Industry -31.03

Net Debt / Equity

-0.76

Sector -0.72

Industry -0.72

Gross Debt / Equity

0.00

Sector 0.21

Industry 0.21

Equity/Assets

0.97

Sector 0.43

Industry 0.43

Liabilities/Assets

0.03

Sector 0.52

Industry 0.52

Growth

5Y Revenue CAGR

0.00%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals DNTH

DRAG THE FRAME TO SEE MORE DATA

DNTH Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

- year

Founded:

Time since IPO - - year

-

Employees

Dianthus Therapeutics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $6.42 billion, with shareholders equity totaling $1.17 billion.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Dianthus Therapeutics Inc. reported $1.90 million in revenue, generating net income of $-192.25 million.

Key financial metrics include a P/E ratio of -33.41, a price-to-book (P/B) ratio of 5.48, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker DNTH.

Market cap

$6.42 billion

Net worth

$1.17 billion

$1,172,030,000.00

Assets

$1.21 billion

$1,213,270,000.00

Total Shares Outstanding

56.00 million

56,000,000

Average Daily Trading Volume

$1.16 million

$1,159,534.30

Sector

Others

Industry

Others

DNTH

DNTH revenue and profits

Financial Results DNTH

DRAG THE FRAME TO SEE MORE DATA

DNTH cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

UNH - UnitedHealth Group Incorporated

$388.61 33,84% (12M)

P/E

25.58

2.23%

ROE

13.33%

P/BV

3.41

SHEL - Shell PLC ADR

$92.77 34,82% (12M)

P/E

9.65

3.30%

ROE

14.29%

P/BV

1.38

STLA - Stellantis NV

$5.43 --44,42% (12M)

P/E

-0.61

0.00%

ROE

-35.93%

P/BV

0.22

COR - Cencora Inc.

$317.10 5,40% (12M)

P/E

22.86

0.76%

ROE

81.04%

P/BV

18.52

SSNLF - Samsung Electronics Co Ltd

$- -0,00% (12M)

P/E

13.54

4.85%

ROE

1.69%

P/BV

0.23

ALIZY - Allianz SE ADR

$51.08 --13,60% (12M)

P/E

14.12

2.66%

ROE

17.89%

P/BV

2.53

TTE - TotalEnergies SE ADR

$90.07 54,62% (12M)

P/E

7.06

4.61%

ROE

21.42%

P/BV

1.51

NSRGY - Nestle SA ADR

$99.21 9,18% (12M)

P/E

11.98

4.01%

ROE

58.05%

P/BV

6.96